Navigation Links
OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
Date:3/14/2012

excellence with key opinion leaders in melanoma clinical research for its metastatic melanoma phase II study.

About OncoSec's Metastatic Melanoma Phase II Study (OMS-I100)

A total of up to 25 patients with stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label and multi-center study. The trial is designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with DNA IL-12 and electroporation with a primary endpoint of 24 weeks. One treatment cycle will consist of three treatments applied to up to four lesions on days 1, 5 and 8 with a maximum dose of 1.5 mg DNA IL-12 per treatment cycle. At 12 months, patients will be moved to the follow-up phase of the study and will be followed for up to five years for safety.

OMS ElectroImmunotherapy utilizes OncoSec's proprietary technology to deliver a DNA-based cytokine coded for the immune stimulating agent interleukin-12, or DNA IL-12. The OncoSec Medical System (OMS) applies short electric impulses to the tumor, causing pores to open in the membrane of cancer cells that significantly increases DNA IL-12 uptake into these cells. Phase I data using OMS ElectroImmunotherapy to treat malignant melanoma demonstrated that this therapy was safe and well tolerated. In addition, 53% of patients with distant metastatic lesions demonstrated an objective response, with 15% of these patients having a complete response to the treatment.

About Melanoma

Melanoma is the most serious form of skin cancer. If it is recognized and treated early, it is almost always curable, but if it is not, the cancer can advance and spread to other parts of the body, where it becomes hard to treat and can be fatal. While it is not the most common of the skin cancers, it causes the most deaths. The American Cancer Society estimates that at present, about 123,000 new cases of melanoma in the US are diagnos
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy
2. OncoSecs OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper
3. OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
4. OncoSec to Present at World Cancer Immunotherapy Conference
5. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
6. OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
7. OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
8. OncoSec to Present at Medical Device Investor Forum
9. Device Master File for OncoSec Medical System Completed and Submitted to FDA
10. OncoSec Releases Devices for Use in Clinical Trials
11. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Texas , July 30, 2015 /PRNewswire/ ... company focused on gynecologic disease, announced today ... financial results after the market close on ... investor conference call and webcast at 4:30pm ... 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... -- Big Cloud Analytics, Inc. (BCA), a leading provider ... working with Intel Corporation to showcase Internet of ... Healthcare Technology Alliance. The recently formed alliance is ... technology companies and academic institutions. Its purpose is ... in rapidly evolving and growing areas of health ...
(Date:7/30/2015)... July 30, 2015  Lannett Company, Inc. (NYSE: ... at the Canaccord Genuity 35th Annual Growth Conference on ... the InterContinental Boston Hotel.  A webcast ... .  Listeners are encouraged to visit the web site ... the presentation to register, download and install any necessary ...
Breaking Medicine Technology:Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3
... NEW YORK, Nov. 28, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0692953/Pharmaceutical-Packaging-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Packaging ... Summary ...
... 28, 2011  Inspiration Biopharmaceuticals, Inc. (Inspiration) today ... second of two pivotal studies in the Company,s ... initiated clinical study, OBI-1, an intravenous recombinant porcine ... the treatment of individuals with congenital hemophilia A ...
Cached Medicine Technology:Pharmaceutical Packaging Industry - 2011 Yearbook 2Pharmaceutical Packaging Industry - 2011 Yearbook 3Pharmaceutical Packaging Industry - 2011 Yearbook 4Pharmaceutical Packaging Industry - 2011 Yearbook 5Pharmaceutical Packaging Industry - 2011 Yearbook 6Pharmaceutical Packaging Industry - 2011 Yearbook 7Pharmaceutical Packaging Industry - 2011 Yearbook 8Pharmaceutical Packaging Industry - 2011 Yearbook 9Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 2Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 3Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 4Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 5
(Date:7/30/2015)... ... July 30, 2015 , ... Well-known San ... the largest, family-owned low cost service and repair companies. For 35 years, they ... as growing their company to meet the demands of the changing technological environment. ...
(Date:7/30/2015)... County, CA (PRWEB) , ... July 30, 2015 ... ... home health care throughout Orange, Riverside, Los Angeles, and San Bernardino counties, today ... as the new Palliative Care Administrator. Dr. Demoratz is a strong proponent of ...
(Date:7/30/2015)... Beach, CA (PRWEB) , ... ... ... Center recently released a video, “Beachside Nursing Center,” to announce its position ... and five-star ratings. Beachside's administrator and staff members support the CMS rating ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... Program and fourth annual Institute Scholar Program. In partnership with Patient Experience Institute, ... patient experience, develop leaders on the front lines and throughout the experience movement, ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, MD, FACS ... as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ second appointment by ... with the university, developing a strong presence and a valuable mentoring program for medical ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:Beachside Nursing Center Releases New Video 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3
... Members, WASHINGTON, Oct. 26 The Alliance of,Community ... its member,plans have been recognized by the U.S. News ... (NCQA) as being among the top 25,health plans in ... ACHP members are select regional health plans that ...
... ... and teens, RICHMOND, Va., Oct. ... preventing drunk driving and,underage drinking with new 30-second radio public service announcements,(PSAs) ... to,coincide with the busy fall season and will air more than 4,000 ...
... on anti-aging and ... personal beauty, ... launch of the first consumer website dedicated,to consumer reviews and expert ... in an,open and honest conversation about important decisions that affect the ...
... Uroplasty, Inc. (Amex:,UPI) announced today that it ... fiscal 2008 ended September 30, 2007, before the ... will host a conference call to,discuss these results ... Central,Time. David Kaysen, President and Chief Executive Officer ...
... - Providers Now Able to Submit Aetna Claims at ... MD On-Line, Inc., a leading,healthcare technology company focused on ... and payers, today,announced it has expanded its relationship with ... of October 1, 2007. Aetna is a leading,diversified health ...
... EP MedSystems,(Nasdaq: EPMD ) announces the following Webcast: What: ... 4:30 pm EST, Where: http://www.videonewswire.com/event.asp?id=43653 , How: ... web at the ... 856-753-8533, If ...
Cached Medicine News:Health News:Community Health Plans Among Best in Nation 2Health News:Community Health Plans Among Best in Nation 3Health News:Community Health Plans Among Best in Nation 4Health News:Community Health Plans Among Best in Nation 5Health News:Virginia Attorney General Addresses Drunk Driving and Underage Drinking in New Radio Campaign 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 3Health News:MD On-Line Expands Relationship with Aetna for Direct Claim Submission 2Health News:Webcast Alert: EP MedSystems Announces EP MedSystems Third Quarter 2007 Earnings Conference Call Webcast 2
... an "assembly-line worker" for routine staining protocols ... It automatically stains big quantities of slides ... number of reagent stations in combination with ... throughput. Up to 12 baskets with 30 ...
HMS 760 Robot Stainer. Version includes display....
For the quantitative determination of total cholesterol in serum....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
Medicine Products: